238 related articles for article (PubMed ID: 33921413)
1. Natural Killer Cells in Post-Transplant Lymphoproliferative Disorders.
Nakid-Cordero C; Baron M; Guihot A; Vieillard V
Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33921413
[TBL] [Abstract][Full Text] [Related]
2. Co-infection of Cytomegalovirus and Epstein-Barr Virus Diminishes the Frequency of CD56
Lam JKP; Azzi T; Hui KF; Wong AMG; McHugh D; Caduff N; Chan KH; Münz C; Chiang AKS
Front Immunol; 2020; 11():1231. PubMed ID: 32625211
[TBL] [Abstract][Full Text] [Related]
3. Role of Epstein-Barr virus status and immunophenotypic studies in the evaluation of exfoliative cytology specimens from patients with post-transplant lymphoproliferative disorders.
Gibson SE; Picarsic J; Swerdlow SH; Pantanowitz L
Cancer Cytopathol; 2016 Jun; 124(6):425-35. PubMed ID: 26992116
[TBL] [Abstract][Full Text] [Related]
4. Post Transplant Lymphoproliferative Disorder.
Gupta D; Mendonca S; Chakraborty S; Chatterjee T
Indian J Hematol Blood Transfus; 2020 Apr; 36(2):229-237. PubMed ID: 32425371
[TBL] [Abstract][Full Text] [Related]
5. [Post-transplant lymphoproliferative disease in liver transplant recipients--Merkur University Hospital single center experience].
Filipec-Kanizaj T; Budimir J; Colić-Cvrlje V; Kardum-Skelin I; Sustercić D; Naumovski-Mihalić S; Mrzljak A; Kolonić SO; Sobocan N; Bradić T; Dolić ZM; Kocman B; Katicić M; Zidovec-Lepej S; Vince A
Acta Med Croatica; 2011 Sep; 65 Suppl 1():37-43. PubMed ID: 23126028
[TBL] [Abstract][Full Text] [Related]
6. Epstein-Barr virus-associated T-cell lymphoma in solid organ transplant recipients.
Sivaraman P; Lye WC
Biomed Pharmacother; 2001 Sep; 55(7):366-8. PubMed ID: 11669498
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of post-transplant lymphoproliferative disorders of donor origin occurring in liver transplant recipients.
Capello D; Rasi S; Oreste P; Veronese S; Cerri M; Ravelli E; Rossi D; Minola E; Colosimo A; Gambacorta M; Muti G; Morra E; Gaidano G
J Pathol; 2009 Aug; 218(4):478-86. PubMed ID: 19391128
[TBL] [Abstract][Full Text] [Related]
8. Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disorders after Hematopoietic Stem Cell Transplantation: Pathogenesis, Risk Factors and Clinical Outcomes.
Fujimoto A; Suzuki R
Cancers (Basel); 2020 Feb; 12(2):. PubMed ID: 32024048
[TBL] [Abstract][Full Text] [Related]
9. Viral load of EBV DNAemia is a predictor of EBV-related post-transplant lymphoproliferative disorders in pediatric renal transplant recipients.
Colombini E; Guzzo I; Morolli F; Longo G; Russo C; Lombardi A; Merli P; Barzon L; Murer L; Piga S; Ciofi Degli Atti ML; Locatelli F; Dello Strologo L
Pediatr Nephrol; 2017 Aug; 32(8):1433-1442. PubMed ID: 28280938
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity?
Nelson BP; Nalesnik MA; Bahler DW; Locker J; Fung JJ; Swerdlow SH
Am J Surg Pathol; 2000 Mar; 24(3):375-85. PubMed ID: 10716151
[TBL] [Abstract][Full Text] [Related]
11. Management of post-transplant Epstein-Barr virus-related lymphoproliferative disease in solid organ and hematopoietic stem cell recipients.
Marques HH; Shikanai-Yasuda MA; dAzevedo LS; Caiaffa-Filho HH; Pierrotti LC; Aquino MZ; Lopes MH; Maluf NZ; Campos SV; Costa SF
Rev Soc Bras Med Trop; 2014; 47(5):543-6. PubMed ID: 25467252
[TBL] [Abstract][Full Text] [Related]
12. The Immune Response to Epstein Barr Virus and Implications for Posttransplant Lymphoproliferative Disorder.
Martinez OM; Krams SM
Transplantation; 2017 Sep; 101(9):2009-2016. PubMed ID: 28376031
[TBL] [Abstract][Full Text] [Related]
13. The diverse pathology of post-transplant lymphoproliferative disorders: the importance of a standardized approach.
Nalesnik MA
Transpl Infect Dis; 2001 Jun; 3(2):88-96. PubMed ID: 11395974
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus-induced T cell lymphoma in solid organ transplant recipients.
Dockrell DH; Strickler JG; Paya CV
Clin Infect Dis; 1998 Jan; 26(1):180-2. PubMed ID: 9455529
[TBL] [Abstract][Full Text] [Related]
15. The Tumor Microenvironment in Post-Transplant Lymphoproliferative Disorders.
Marcelis L; Tousseyn T
Cancer Microenviron; 2019 Apr; 12(1):3-16. PubMed ID: 30680693
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr Virus-Related Post-Transplant Lymphoproliferative Disorders in Cystic Fibrosis Lung Transplant Recipients: A Case Series.
Mendogni P; Henchi S; Morlacchi LC; Tosi D; Nosotti M; Tarsia P; Gregorini AI; Rosso L
Transplant Proc; 2019; 51(1):194-197. PubMed ID: 30655153
[TBL] [Abstract][Full Text] [Related]
17. Epstein-Barr virus-related post-transplant lymphoproliferative disorder in solid organ transplant recipients.
San-Juan R; Comoli P; Caillard S; Moulin B; Hirsch HH; Meylan P;
Clin Microbiol Infect; 2014 Sep; 20 Suppl 7():109-18. PubMed ID: 24475976
[TBL] [Abstract][Full Text] [Related]
18. Surveillance of Epstein-Barr virus infection as a risk factor for post-transplant lymphoproliferative disorder in pediatric renal transplant recipients.
Köpf S; Tönshoff B
Pediatr Nephrol; 2004 Apr; 19(4):365-8. PubMed ID: 14963763
[TBL] [Abstract][Full Text] [Related]
19. Characteristic pattern of chromosomal imbalances in posttransplantation lymphoproliferative disorders: correlation with histopathological subcategories and EBV status.
Poirel HA; Bernheim A; Schneider A; Meddeb M; Choquet S; Leblond V; Charlotte F; Davi F; Canioni D; Macintyre E; Mamzer-Bruneel MF; Hirsch I; Hermine O; Martin A; Cornillet-Lefebvre P; Patey M; Toupance O; Kémény JL; Deteix P; Raphaël M
Transplantation; 2005 Jul; 80(2):176-84. PubMed ID: 16041261
[TBL] [Abstract][Full Text] [Related]
20. T-cell post-transplantation lymphoproliferative disorders after cardiac transplantation: a single institutional experience.
Draoua HY; Tsao L; Mancini DM; Addonizio LJ; Bhagat G; Alobeid B
Br J Haematol; 2004 Nov; 127(4):429-32. PubMed ID: 15521920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]